Invention Grant
- Patent Title: Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof
-
Application No.: US16603719Application Date: 2018-04-04
-
Publication No.: US11136296B2Publication Date: 2021-10-05
- Inventor: Hartmut Beck , Raimund Kast , Mark Meininghaus , Lisa Dietz , Chantal Fuerstner , Timo Stellfeld , Sonja Anlauf , Clemens-Jeremias Von Buehler , Michaela Bairlein , Johanna Anlahr , Uwe Muenster , Carsten Terjung , Hannah Joerissen , Peter Hauff , Joerg Mueller , Karoline Droebner , Jens Nagel
- Applicant: Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft
- Applicant Address: DE Leverkusen; DE Berlin
- Assignee: Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- Current Assignee: Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- Current Assignee Address: DE Leverkusen; DE Berlin
- Agency: McBee Moore & Vanik IP, LLC
- Priority: EP17165673 20170410
- International Application: PCT/EP2018/058611 WO 20180404
- International Announcement: WO2018/189011 WO 20181018
- Main IPC: C07D215/50
- IPC: C07D215/50
Abstract:
The present application relates to novel substituted N-arylethyl-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.
Public/Granted literature
- US20200031775A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Public/Granted day:2020-01-30
Information query
